10-K/A XBRL

FORM 10-K/A

Company: Eton Pharmaceuticals, Inc.
Filed: March 22, 2024
Period of Report: December 31, 2023
Accession Number: 0001437749-24-009052

View Document ↗ View on SEC.gov ↗